cryptotanshinone has been researched along with Polycystic Ovary Syndrome in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, L; Liu, H; Ni, X; Peng, X; Xia, Y; Xie, J; Zhou, J | 1 |
| Dou, X; Wang, B; Wang, F; Wen, M; Xu, J; Zhang, S; Zhang, W | 1 |
| Guo, Y; Han, FJ; Li, J; Liu, YC; Lu, WH; Wang, JW; Wu, Q | 1 |
| Hu, G; Ni, X; Qi, C; Sun, Z; Wang, L; Yang, L; Yang, Y | 1 |
| Jin, X; Ong, M; Peng, J; Qu, X | 1 |
| Huang, Y; Li, W; Wang, CC; Wu, X; Zheng, J | 1 |
| Li, XH; Wu, XK; Yang, XM | 1 |
| Bae, CS; Hou, L; Kuang, H; Stener-Victorin, E; Wang, Y; Wu, X; Yang, X; Zhang, Y | 1 |
1 review(s) available for cryptotanshinone and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
Chinese Herbal Medicine for the Optimal Management of Polycystic Ovary Syndrome.
Topics: Androgens; Berberine; Drugs, Chinese Herbal; Female; Ginsenosides; Glucosides; Humans; Insulin Resistance; Monoterpenes; Phenanthrenes; Phytotherapy; Polycystic Ovary Syndrome; Resveratrol; Stilbenes; Theca Cells | 2017 |
7 other study(ies) available for cryptotanshinone and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
Cryptotanshinone Protects against PCOS-Induced Damage of Ovarian Tissue via Regulating Oxidative Stress, Mitochondrial Membrane Potential, Inflammation, and Apoptosis via Regulating Ferroptosis.
Topics: Animals; Apoptosis; Female; Ferroptosis; Humans; Inflammation; Matrix Metalloproteinases; Membrane Potential, Mitochondrial; Oxidative Stress; Phenanthrenes; Polycystic Ovary Syndrome; Rats | 2022 |
CTBP1‑AS upregulation is associated with polycystic ovary syndrome and can be effectively downregulated by cryptotanshinone.
Topics: Alcohol Oxidoreductases; DNA-Binding Proteins; Female; Humans; Phenanthrenes; Polycomb Repressive Complex 2; Polycystic Ovary Syndrome; RNA, Antisense; Transcriptional Activation; Up-Regulation | 2022 |
Mechanism of cryptotanshinone to improve endocrine and metabolic functions in the endometrium of PCOS rats.
Topics: Animals; Endometrium; Estrogens; Female; Humans; Polycystic Ovary Syndrome; Quality of Life; Rats | 2024 |
Cryptotanshinone alleviates polycystic ovary syndrome in rats by regulating the HMGB1/TLR4/NF‑κB signaling pathway.
Topics: Animals; Body Weight; Cell Proliferation; Cell Survival; Disease Models, Animal; Female; Gene Expression Regulation; HMGB1 Protein; NF-kappa B; Organ Size; Phenanthrenes; Polycystic Ovary Syndrome; Rats; Signal Transduction; Toll-Like Receptor 4 | 2020 |
Cryptotanshinone reverses ovarian insulin resistance in mice through activation of insulin signaling and the regulation of glucose transporters and hormone synthesizing enzymes.
Topics: Animals; Blood Glucose; Dexamethasone; Disease Models, Animal; Estradiol; Female; Gene Expression Regulation, Enzymologic; Glucose Metabolism Disorders; Glucose Transport Proteins, Facilitative; Insulin; Insulin Resistance; Mice; Ovary; Ovulation; Phenanthrenes; Phosphatidylinositol 3-Kinase; Polycystic Ovary Syndrome; Proto-Oncogene Proteins c-akt; Signal Transduction; Steroid 17-alpha-Hydroxylase; Testosterone; Tissue Culture Techniques | 2014 |
[Effects of cryptotanshinone in lowering androgens synthesis for the prenatally androgenized male rats].
Topics: Androgens; Animals; Disease Models, Animal; Female; Humans; Male; Maternal Exposure; Phenanthrenes; Polycystic Ovary Syndrome; Pregnancy; Prenatal Exposure Delayed Effects; Random Allocation; Rats; Rats, Wistar | 2008 |
Cryptotanshinone reverses reproductive and metabolic disturbances in prenatally androgenized rats via regulation of ovarian signaling mechanisms and androgen synthesis.
Topics: 17-alpha-Hydroxyprogesterone; Androgens; Androstenedione; Animals; Drugs, Chinese Herbal; Female; Glucose; Insulin; Insulin Resistance; Models, Animal; Ovary; Phenanthrenes; Polycystic Ovary Syndrome; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Reproduction; Signal Transduction; Testosterone | 2011 |